| J9271 | Injection, pembrolizumab, 1 mg | 7,600 | $40 | $327K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 6,300 | $40 | $239.4K |
| J0897 | Injection, denosumab, 1 mg | 2,520 | $20 | $47.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 220 | $90 | $20.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 180 | $100 | $18K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 130 | $130 | $16.9K |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 730 | $20 | $15.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 180 | $60 | $11K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 60 | $80 | $4.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 30 | $120 | $3.6K |